Skip to main
RVTY
RVTY logo

Revvity Inc (RVTY) Stock Forecast & Price Target

Revvity Inc (RVTY) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 31%
Buy 46%
Hold 23%
Sell 0%
Strong Sell 0%

Bulls say

Revvity exhibits a strong upward trajectory in growth, underpinned by a strategic shift to IGRA testing, which is expected to increase market share by several basis points annually. The company has enhanced its financial profile through the successful integration of high-growth segments, including software solutions and a leading life sciences reagents franchise, which altogether enhance profitability and cross-selling opportunities. Furthermore, ongoing improvements in margins, driven by operational leverage and substantial topline growth, position Revvity favorably to capitalize on increasing demand within its key markets.

Bears say

Revvity's financial outlook is negatively impacted by significant declines in its China operations, particularly in the Immunodiagnostics segment, which decreased by an unspecified double-digit percentage in the second quarter of 2025, contributing to an overall revenue drop of mid-single digits. The company faces risks from poor economic conditions and potential funding cuts, which could lead to decreased customer demand for its offerings, thereby affecting growth and market share. Additionally, macroeconomic factors such as inflation, product shortages, and labor issues could further disrupt Revvity's supply chain, hampering its ability to deliver products effectively.

Revvity Inc (RVTY) has been analyzed by 13 analysts, with a consensus rating of Buy. 31% of analysts recommend a Strong Buy, 46% recommend Buy, 23% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Revvity Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Revvity Inc (RVTY) Forecast

Analysts have given Revvity Inc (RVTY) a Buy based on their latest research and market trends.

According to 13 analysts, Revvity Inc (RVTY) has a Buy consensus rating as of Nov 4, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $118, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $118, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Revvity Inc (RVTY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.